This inventor holds 1 USPTO granted patent. Top assignee: Bayer Animal Health Gmbh. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Joerg Wirths: Innovator in Quinolonecarboxylic Ester Hydrolysis
Introduction
Joerg Wirths is a notable inventor based in Essen, Germany. He has made significant contributions to the field of chemistry, particularly in the hydrolysis of quinolonecarboxylic esters. His innovative methods have implications for pharmaceutical synthesis, showcasing his expertise and dedication to advancing scientific knowledge.
Latest Patents
Wirths holds a patent for a method for the hydrolysis of quinolonecarboxylic esters. This method involves reacting compounds of the general formula (II) with a mixture of acetic acid, sulfuric acid, and water. Specifically, the process utilizes ≥30 to ≤40 mol of acetic acid, ≥0.3 to ≤1 mol of sulfuric acid, and ≥0.9 to ≤2.5 mol of water per mole of the compounds. This technique is particularly suitable for synthesizing the intermediate (I) in the production of pradofloxacin.
Career Highlights
Joerg Wirths is currently associated with Bayer Animal Health GmbH, where he continues to apply his expertise in chemical synthesis. His work has contributed to the development of important pharmaceutical compounds, enhancing the capabilities of the company in the animal health sector.
Collaborations
Wirths has collaborated with esteemed colleagues such as Mathias Berwe and Ralf Wischnat. These partnerships have fostered a collaborative environment that promotes innovation and the sharing of ideas within the field.
Conclusion
Joerg Wirths is a distinguished inventor whose work in the hydrolysis of quinolonecarboxylic esters has made a significant impact in the pharmaceutical industry. His contributions continue to influence advancements in chemical synthesis and animal health.